S. Muoio & Co’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

S. Muoio & Co’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-52,468	Closed	-$964K	–	92
2020 Q4	$964K	Buy	52,468 +12,468	+31%	+$227K	1.05%	39
2020 Q3	$734K	Buy	+40,000	New	+$672K	0.83%	44

S. Muoio & Co's CBMG Position: Q1 2021 in Review

S. Muoio & Co sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 52,468 shares — an estimated $964K sold.

S. Muoio & Co first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $964K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

S. Muoio & Co reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
S. Muoio & Co sold 52,468 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $964K.
S. Muoio & Co first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
S. Muoio & Co's Cellular Biomedicine Group, Inc. position peaked at $964K in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on S. Muoio & Co's 13F filing for Q1 2021, filed 14 May 2021.